Skip to content

Drug and Alcohol Dependence

ISSN 0376-8716, 1879-0046

155 papers in the library · 2,092 citations · publishing 1978-2026

Papers

Sort Most recent Most cited

Regular cannabis and alcohol use is associated with resting-state time course power spectra in incarcerated adolescents

Drug and Alcohol Dependence July 8, 2017 Sandra Thijssen, B. Rashid, Shruti Gopal et al.

Cannabis and alcohol are believed to have widespread effects on the brain. Although adolescents are at increased risk for substance use, the adolescent brain may also be particularly vulnerable to the effects of drug exposure due to its rapid maturation. Here, we examined the association between cannabis and alcohol use duration and resting-state functional connectivity in a large sample of...

Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients

Drug and Alcohol Dependence March 29, 2017 Eric L Garland, Craig J. Bryan, Patrick H. Finan et al. 74 citations

BACKGROUND: Given the risk of opioid misuse among chronic pain patients being treated with long-term opioid pharmacotherapy, non-pharmacological treatments are needed. Further, in light of hedonic deficits in this population, therapies that enhance positive affect may be useful. The purpose of this study was to examine effects of a Mindfulness-Oriented Recovery Enhancement (MORE) intervention...

Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.

Drug and Alcohol Dependence March 1, 2017 Jenny L Wiley, Timothy W Lefever, Julie A. Marusich et al.

Women report greater sensitivity to the subjective effects of Δ9-tetrahydrocannabinol (THC). Similarly, female rodents tend to be more sensitive to some pharmacological effects of THC and synthetic cannabinoids. This study examined sex differences in discriminative stimulus and response rate effects of THC and synthetic cannabinoids in rats. A cumulative dosing THC discrimination procedure was...

Ibogaine for treating drug dependence. What is a safe dose?

Drug and Alcohol Dependence September 1, 2016 Leo J. Schep, Robin J Slaughter, S Galea et al. 30 citations

The indole alkaloid ibogaine, present in the root bark of the West African rain forest shrub Tabernanthe iboga, has been adopted in the West as a treatment for drug dependence. Treatment of patients requires large doses of the alkaloid to cause hallucinations, an alleged integral part of the patient's treatment regime. However, case reports and case series continue to describe evidences of...

DOI: 10.1016/j.drugalcdep.2016.07.005 (opens in new tab) Full text (opens in new tab) Drug dependence Qt prolongation Ibogaine treatment ibogaine Current ibogaine doses +6

Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.

Drug and Alcohol Dependence August 1, 2016 Lance R Mcmahon

Cannabidiol, a therapeutic with potential serotonin (5-hydroxytryptamine; 5-HT) 5-HT1A receptor agonist activity, is the second most prevalent cannabinoid in Cannabis after Δ(9)-THC. The extent to which cannabidiol modifies the effects of Δ(9)-THC has not been firmly established, especially with respect to abuse-related effects in rhesus monkeys where previously antagonistic interactions have...

Benzylpiperazine: "A messy drug".

Drug and Alcohol Dependence July 1, 2016 D P Katz, Jack DeRuiter, D Bhattacharya et al.

Designer drugs are synthetic structural analogues/congeners of controlled substances with slightly modified chemical structures intended to mimic the pharmacological effects of known drugs of abuse so as to evade drug classification. Benzylpiperazine (BZP), a piperazine derivative, elevates synaptic dopamine and serotonin levels producing stimulatory and hallucinogenic effects, respectively,...

DOI: 10.1016/j.drugalcdep.2016.04.010 (opens in new tab) Full text (opens in new tab) Benzylpiperazine Designer drugs Monoaminergic toxicity Piperazine derivatives +2

Mindfulness meditation improves emotion regulation and reduces drug abuse.

Drug and Alcohol Dependence June 1, 2016 Yi-Yuan Tang, Rongxiang Tang, Michael I Posner

The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activity in anterior cingulate cortex (ACC), adjacent prefrontal cortex (mPFC) and other brain areas. Behavioral...

DOI: 10.1016/j.drugalcdep.2015.11.041 (opens in new tab) Full text (opens in new tab) Brain mechanism Emotion regulation Implusivity Mindfulness meditation +2

Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.

Drug and Alcohol Dependence March 1, 2016 Yoko Nawata, Kiyoyuki Kitaichi, Tsuneyuki Yamamoto

3,4-Methylenedioxymethamphetamine (MDMA), a methamphetamine (METH) derivative, exhibits METH-like actions at monoamine transporters and positive reinforcing effects in rodents and primates. The purposes of the present study were to determine whether cross-reinstatement would be observed between MDMA and METH and if the cannabinoid receptor, a receptor known to play critical roles in the brain...

DOI: 10.1016/j.drugalcdep.2015.12.016 (opens in new tab) Full text (opens in new tab) MDMA Cb1 cannabinoid receptor Drug-seeking behavior Methamphetamine +1

Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.

Drug and Alcohol Dependence December 1, 2015 Johanna J Nugteren-Van Lonkhuyzen, Antoinette J H P van Riel, Tibor M Brunt et al. 48 citations

Recently, the number of new psychoactive substances (NPS) appearing on the illicit drug market has shown a marked increase. Although many users perceive the risk of using NPS as medium or low, these substances can pose a serious health risk and several NPS have been implicated in drug-related deaths. In Europe, frequently detected NPS are 4-bromo-2,5-dimethoxyphenethylamine (2C-B),...

DOI: 10.1016/j.drugalcdep.2015.10.011 (opens in new tab) Full text (opens in new tab) Designer drugs Legal highs Research chemicals New psychoactive substances +15

Next generation of novel psychoactive substances on the horizon - A complex problem to face.

Drug and Alcohol Dependence December 1, 2015 Jolanta B. Zawilska, Dariusz Andrzejczak

The last decade has seen a rapid and continuous growth in the availability and use of novel psychoactive substances (NPS) across the world. Although various products are labeled with warnings "not for human consumption", they are intended to mimic psychoactive effects of illicit drugs of abuse. Once some compounds become regulated, new analogues appear in order to satisfy consumers' demands and...

DOI: 10.1016/j.drugalcdep.2015.09.030 (opens in new tab) Full text (opens in new tab) Cathinones Methoxetamine Nbome compounds Novel psychoactive substances +4

Safety of oral dronabinol during opioid withdrawal in humans.

Drug and Alcohol Dependence December 1, 2015 Crystal J Jicha, Michelle R Lofwall, Paul A Nuzzo et al.

Opioid dependence remains a significant public health problem worldwide with only three FDA-approved treatments, all targeting the mu-opioid receptor. Dronabinol, a cannabinoid (CB) 1 receptor agonist, is currently under investigation as a novel opioid withdrawal treatment. This study reports on safety outcomes of dronabinol among adults in opioid withdrawal. Twelve adults physically dependent...

DOI: 10.1016/j.drugalcdep.2015.09.031 (opens in new tab) Full text (opens in new tab) Dronabinol Opioid dependence Opioid withdrawal Safety +1

Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts

Drug and Alcohol Dependence November 1, 2015 Albert Garcia‐romeu, Tehseen Noorani, Roland R. Griffiths et al. 6 citations

Aims: We assessed long-term (>12 months) outcomes of psilocybin-facilitated smoking cessation, and qualitatively analyzed participants’ accounts to inform potential psychological mechanisms of treatment efficacy. Methods: Fifteen individuals who completed a pilot study of psilocybin-facilitated smoking cessation were invited for a long-term follow-up. Eleven (73%) returned and were interviewed...

DOI: 10.1016/j.drugalcdep.2015.07.1130 (opens in new tab) Endocannabinoid system Cannabinoid receptor 2-arachidonoylglycerol Norepinephrine +5

Cortical thinness and volume differences associated with marijuana abuse in emerging adults.

Drug and Alcohol Dependence October 1, 2015 Yasmin Mashhoon, S Sava, Jennifer T Sneider et al.

The prevalence of marijuana (MJ) use among youth and its legalization for medical or recreational use has intensified public health endeavors of understanding MJ effects on brain structure and function. Studies indicate that MJ use is related to impaired cognitive performance, and altered functional brain activation and chemistry in adolescents and adults, but MJ effects on brain morphology in...

Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.

Drug and Alcohol Dependence September 3, 2015 Joseph J Palamar, Silvia S Martins, Mark K Su et al.

Background: In recent years, there has been an increase in emergence and use of novel psychoactive substances (NPS) in the US and worldwide. However, there is little published epidemiological survey data estimating the prevalence of use in the US. Method: Data on self-reported NPS use came from the National Survey of Drug Use and Health (2009-2013), a national representative sample of...

DOI: 10.1016/j.drugalcdep.2015.08.028 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders Tryptamines N,N-Dimethyltryptamine +18

Recreational phenethylamine poisonings reported to a French poison control center.

Drug and Alcohol Dependence September 1, 2015 Gaël Le Roux, Chloé Bruneau, Benedicte Lelievre et al.

Over the last decade, use of phenethylamines has become increasingly prevalent. This study aimed to describe typical aspects of phenethylamine poisoning in order to better inform patient care. Phenethylamine poisoning cases reported to the Poison Control Center of Angers, France, from January, 2007 to December, 2013 were examined. Clinical findings were examined in 105 patients, including...

DOI: 10.1016/j.drugalcdep.2015.05.048 (opens in new tab) Full text (opens in new tab) Amphetamines Designer drugs Phenethylamines Poison control center +1

Cannabis, cigarettes, and their co-occurring use: disentangling differences in default mode network functional connectivity

Drug and Alcohol Dependence June 10, 2015 Reagan R Wetherill, Zhuo Fang, Kanchana Jagannathan et al.

Background Resting-state functional connectivity is a noninvasive, neuroimaging method for assessing neural network function. Altered functional connectivity among regions of the default-mode network have been associated with both nicotine and cannabis use; however, less is known about co-occurring cannabis and tobacco use. Methods We used posterior cingulate cortex (PCC) seed-based...

One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone.

Drug and Alcohol Dependence June 1, 2015 Shawn. M. Aarde, Michelle L Miller, Kevin M Creehan et al.

Exercise influences drug craving and consumption in humans and drug self-administration in laboratory animals, but the effects can be variable. Improved understanding of how exercise affects drug intake or craving would enhance applications of exercise programs to human drug users attempting cessation. Rats were trained in the intravenous self-administration (IVSA) of D-methamphetamine (METH;...

DOI: 10.1016/j.drugalcdep.2015.03.016 (opens in new tab) Full text (opens in new tab) Bathsalts Exercise Reinforcement Self-administration +1

Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.

Drug and Alcohol Dependence April 1, 2015 Leslie H. Lundahl, Mark K Greenwald

The current study tested whether oral Δ(9)-tetrahydrocannabinol (THC: 0-, 10-, and 20-mg) pretreatment would attenuate polysensory cue-induced craving for marijuana. Cannabis dependent participants (7 males and 7 females, who smoked on average 5.4 ± 1.1 blunts daily) completed 3 experimental sessions (oral THC pretreatment dose; counterbalanced order) using a placebo-controlled within-subject...

Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.

Drug and Alcohol Dependence February 1, 2015 Laura Hondebrink, Johanna J Nugteren-Van Lonkhuyzen, Daan van der Gouwe et al. 119 citations

In recent years, the number of new psychoactive substances (NPS) appearing on the illicit drug market strongly increased. However, little is known about their toxic effects and risks. Therefore, we determined the most frequently occurring NPS in The Netherlands and combined this with data regarding drug-related intoxications. Data from the Drugs Information and Monitoring System (DIMS) and the...

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Drug and Alcohol Dependence November 1, 2014 Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers et al.

Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe the endogenous cannabinoid system or as potential therapeutics. Clandestine laboratories subsequently utilized published data to develop SC variations marketed as abusable designer drugs. In the early 2000s, SC became popular as "legal highs" under brand names such as Spice and K2, in part due to their ability...

DOI: 10.1016/j.drugalcdep.2014.08.005 (opens in new tab) Full text (opens in new tab) Cb1/cb2 agonists Designer drug Epidemiology Pharmacodynamics +2

Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.

Drug and Alcohol Dependence October 1, 2014 Joshua A Lile, Thomas H Kelly, Lon R Hays

Our previous research suggested the involvement of γ-aminobutyric acid (GABA), in particular the GABAB receptor subtype, in the interoceptive effects of Δ(9)-tetrahydrocannabinol (Δ(9)-THC). The aim of the present study was to determine the potential involvement of the GABAA receptor subtype by assessing the separate and combined effects of the GABAA positive allosteric modulator diazepam and...

DOI: 10.1016/j.drugalcdep.2014.07.016 (opens in new tab) Full text (opens in new tab) Marijuana Cardiovascular Digit-symbol-substitution task Drug discrimination +2

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

Drug and Alcohol Dependence January 15, 2014 Elias Dakwar, C. Anerella, Carl L. Hart et al. 125 citations

Background Sub-anesthetic ketamine infusions may benefit a variety of psychiatric disorders, including addiction. Though ketamine engenders transient alterations in consciousness, it is not known whether these alterations influence efficacy. This analysis evaluates the mystical-type effects of ketamine, which may have therapeutic potential according to prior research, and assesses whether these...

A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.

Drug and Alcohol Dependence June 1, 2013 Robert M. Hallock, Andrew Dean, Zachary A Knecht et al.

Recreational usage and attitudes toward psilocybin-containing hallucinogenic mushrooms among college students are seldom explored. We surveyed 882 randomly selected undergraduates at Skidmore College in upstate New York and quantified whether participants had ever used psilocybin mushrooms, their attitudes toward the drug, and polydrug use. There were 409 responses and 29.5% of the sample...

Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature.

Drug and Alcohol Dependence May 8, 2013 Laura Carim-Todd, Suzanne H. Mitchell, Barry Oken

Objective: The limited success of current smoking cessation therapies encourages research into new treatment strategies. Mind-body practices such as yoga and meditation have the potential to aid smoking cessation and become an alternative drug-free treatment option. The aim of this article is to assess the efficacy of yoga and other meditation-based interventions for smoking cessation, to...

Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

Drug and Alcohol Dependence March 1, 2013 Lawrence P Carter, Chad J Reissig, Matthew W Johnson et al. 28 citations

Although concerns surrounding high-dose dextromethorphan (DXM) abuse have recently increased, few studies have examined the acute cognitive effects of high doses of DXM. The aim of this study was to compare the cognitive effects of DXM with those of triazolam and placebo. Single, acute, oral doses of DXM (100, 200, 300, 400, 500, 600, 700, 800 mg/70 kg), triazolam (0.25, 0.5mg/70 kg), and...

DOI: 10.1016/j.drugalcdep.2012.08.025 (opens in new tab) Full text (opens in new tab) Dextromethorphan Cough suppressant Antitussive Otc medication +19